About Cybele Microbiome
Cybele Microbiome is a company based in San Diego (United States) founded in 2017 by Nicole Scott and Eddie Adams.. Cybele Microbiome has raised $1.9 million across 5 funding rounds from investors including IndieBio and National Science Foundation. Cybele Microbiome offers products and services including Rulo Skin Health and Microbiome Technology. Cybele Microbiome operates in a competitive market with competitors including Avidity Biosciences, Metabolon, Univercells, Sutro Biopharma and Maze Therapeutics, among others.
- Headquarter San Diego, United States
- Founders Nicole Scott, Eddie Adams
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cybele Microbiome, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.9 M (USD)
in 5 rounds
-
Latest Funding Round
$252 K (USD), Seed
Feb 20, 2024
-
Investors
IndieBio
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cybele Microbiome
Cybele Microbiome offers a comprehensive portfolio of products and services, including Rulo Skin Health and Microbiome Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for microbiome-based solutions to improve skin efficacy and reduce side effects
Technology analyzing ingredient effects on skin microbiome for health outcomes
Unlock access to complete
Unlock access to complete
Funding Insights of Cybele Microbiome
Cybele Microbiome has successfully raised a total of $1.9M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $252 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $252,000
-
First Round
First Round
(28 Oct 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Seed - Cybele Microbiome | Valuation |
investors |
|
| Nov, 2022 | Amount | Seed - Cybele Microbiome | Valuation |
investors |
|
| Jun, 2020 | Amount | Seed - Cybele Microbiome | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cybele Microbiome
Cybele Microbiome has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include IndieBio and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cybele Microbiome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cybele Microbiome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cybele Microbiome Comparisons
Competitors of Cybele Microbiome
Cybele Microbiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Metabolon, Univercells, Sutro Biopharma and Maze Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cybele Microbiome
When was Cybele Microbiome founded?
Cybele Microbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Cybele Microbiome located?
Cybele Microbiome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Cybele Microbiome?
Nicole Scott is the current CEO of Cybele Microbiome. They have also founded this company.
Is Cybele Microbiome a funded company?
Cybele Microbiome is a funded company, having raised a total of $1.9M across 5 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Oct 28, 2018.
What does Cybele Microbiome do?
Cybele Microbiome was founded in 2017 in San Diego, United States, within the biotechnology sector. Next-generation genetic sequencing methods are utilized by the company to analyze microbiomes and develop prebiotic products aimed at skin health. New biomarkers are also created as part of its operations, with an emphasis on AI-driven platforms for product innovation and analysis.
Who are the top competitors of Cybele Microbiome?
Cybele Microbiome's top competitors include Alector, Sutro Biopharma and Avidity Biosciences.
What products or services does Cybele Microbiome offer?
Cybele Microbiome offers Rulo Skin Health and Microbiome Technology.
Who are Cybele Microbiome's investors?
Cybele Microbiome has 2 investors. Key investors include IndieBio, and National Science Foundation.